Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 3Lymphoid 3Plasma cell 2Other hematologic neoplasm 2Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Leukemia, Myeloid, Acute 54Myelodysplastic Syndromes 46Leukemia 36Lymphoma, Non-Hodgkin 29Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Lymphoma 23Hematologic Neoplasms 20Hodgkin Disease 19Leukemia, Lymphocytic, Chronic, B-Cell 17Burkitt Lymphoma 14Leukemia, Myeloid, Accelerated Phase 13Leukemia, Biphenotypic, Acute 13Blast Crisis 12Multiple Myeloma 11Congenital Abnormalities 11Myeloproliferative Disorders 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10Graft vs Host Disease 10Anemia, Refractory, with Excess of Blasts 10Lymphoma, Mantle-Cell 9Lymphoma, Large B-Cell, Diffuse 9Leukemia, Myeloid, Chronic-Phase 9Dendritic Cell Sarcoma, Interdigitating 9Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myelomonocytic, Juvenile 8Recurrence 7Leukemia, Myelomonocytic, Chronic 7Myelodysplastic-Myeloproliferative Diseases 6

Interventions

Cyclophosphamide 13fludarabine 11Mycophenolic Acid 9Busulfan 8fludarabine phosphate 7Tacrolimus 7pirtobrutinib 6Whole-Body Irradiation 6Rituximab 6Melphalan 6Imatinib Mesylate 5Bone Marrow Transplantation 5ponatinib 4Mesna 4Granulocyte Colony-Stimulating Factor 4Azacitidine 4venetoclax 3nilotinib 3lintuzumab 3Stem Cell Transplantation 3Sirolimus 3Platelet Transfusion 3Methotrexate 3Cytarabine 3Cyclosporine 3Alemtuzumab 3vosaroxin 2ruxolitinib 2ibrutinib 2Thiotepa 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Diseases × Thiotepa × Other hematologic neoplasm × Clear all
NCT04282174 2022-09-27

2019-KOE-001

Baptist Health South Florida

Phase 2 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
176 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡